There were no differences in the use of ACE inhibitors (13.4% vs 9.6%, p = 0.20 respectively) and angiotensin receptor blockers (3.6% vs 2.0%, p = 0.30 respectively) by type of diabetes. This evidence concerns the gene ACE and diabetes mellitus.